NHS National Framework for the supply of Tocilizumab Injection

NHS EnglandcontractFind a TenderRef ocds-h6vhtk-059160Procurement Act 2023SME suitableactive
View buyer

Estimated value

Awarded value

Suppliers

3

Lots

1

1 awarded

Published

30 Dec 2025

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
Matrix - Desk Booking Systemcall off£105k08 May 2026
Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028call off£17k08 May 2026
ID&V Checking Servicecontract£150k08 May 2026
Xerox Managed Print renewal 26/27call off£127k08 May 2026
Manage Engine ServiceDesk Plus Licencescall off£29k08 May 2026
Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026contract£105k08 May 2026
Clinicals Run Maintain Transformcall off£38.0m10 Apr 2026
Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmescontract07 Apr 2026
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiativescontract07 Apr 2026
CPIT System Integration to NHSE RAVScontract£500k01 Apr 2026

Other contracts awarded to Celltrion Healthcare United Kingdom Limited· 10

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →
TitleTypeValuePublished
NHS National Framework Agreement for Omalizumabcontract30 Dec 2025
NHS National Framework for Denosumab Injection commencing 1st January 2026contract04 Dec 2025
NHS National Framework Agreement for Omalizumabcontract28 Nov 2025
NHS National Framework for the supply of Tocilizumab Injectioncontract27 Nov 2025
Branded and Biosimilar Ophthalmologycontract24 Nov 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025contract06 Oct 2025
Project/Contract NHS National Framework for Denosumab Injectioncontract02 Oct 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025contract01 Aug 2025
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025contract£47.0m29 Jul 2025
Biologic and Biosimilar Medicinescontract21 May 2025